ConsenSys Ventures has named the 10 blockchain startups it will fund and mentor this spring through its accelerator program Tachyon. They range from a crypto gift card provider to a peer-to-peer energy-trading platform.
One of those selected is London-based Genomes.io. It wants to use blockchain technology to give users a way to share their DNA data without giving up control of it. Traditionally, if you gave your saliva to a company, like 23andMe, to find out your chance of getting various illnesses, you would have no say over what the company did with your genome next. Whereas if you buy sequencing on Genomes.io’s platform, you get the chance to profit yourself by selling your genetic information.